MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IFRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

InflaRx (IFRX) Ownership - Who owns InflaRx?

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
65
Web
https://www.inflarx.de

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
268.07M
P/E Ratio
N/A
Total Cash
39.8M
Projected Growth
N/A
Total Debt
823.03K
Revenue
29.33K
Risk (Beta)
3.61
Dividend Yield
N/A
Total Cash/Share
0.27
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IFRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IFRX
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
65
Web
https://www.inflarx.de